PRECLINICAL
We have successfully concluded the Preclinical (0 – 3) of over 10 of our Active Pharmaceutical Ingredients for the treatment of varied diseases conditions ranging from Cardio-Metabolic Diseases to Autoimmune-Mediated Diseases with eureka data while other APIs ranging from Ophthalmology to Oncology are on diverse preclinical stages with zenith promising data.
